Skip to main content
. 2015 Oct 23;142:481–487. doi: 10.1007/s00432-015-2055-6

Table 3.

Progression-free survival in months of 198 patients with FIGO IIIC ovarian cancer stratified by cytoreduction

PFS Cytoreduction Median
Months 95 %-CI
FIGO IIIC No residual tumor 28.977 16.241–41.714
≤1 cm residual tumor 18.858 15.243–22.473
>1 cm residual tumor 16.263 13.099–19.426
All 21.027 18.027–24.026